Jaguar Health Approves All Five Proposals at April 20 Special Meeting
Jaguar Health held its Special Meeting of Stockholders on April 20, 2026, at which all five proposals from its March 24 definitive proxy statement were approved. The proposals include corporate governance amendments and strategic authorizations that enable the company’s planned operational initiatives.
1. Special Meeting Results
Jaguar Health convened its Special Meeting of Stockholders on April 20, 2026, where stockholders voted in favor of all five items presented. Each proposal achieved the required votes, ensuring immediate adoption of the measures.
2. Proxy Statement & Next Steps
The five proposals were detailed in the company’s Schedule 14A definitive proxy statement filed on March 24, 2026. With approvals secured, Jaguar Health can implement the governance changes and proceed with the strategic authorizations outlined in the proxy.